醫藥事業:產品研發

新藥研發

Product
Indication
Pre-Clinical
Phase I
Phase II
Phase III

CAR001

惡性腫瘤
Malignant Tumors

0%

Phase I/IIa第1期臨床試驗收案中(Phase I recruiting)


ADCV01

多形性膠質母細胞瘤
Glioblastoma Multiforme ,GBM

0%

Phase II第2期臨床試驗收案中(Phase II recruiting)

UMSC01


急性心肌梗塞
Acute Myocardial Infarction


0%

Phase IIa第IIa期臨床試驗收案中(Phase IIa recruiting)


UMSC01

急性缺血性腦中風
Acute Ischemic

0%

Phase I第1期臨床試驗收案完成(Phase I completed)

UMSC01


新型冠狀病毒感染症
COVID-19


0%

Phase I/IIa第1期臨床試驗收案中(Phase I recruiting)


UMSC01


多發性硬化症
Multiple sclerosis


0%

Phase I/IIa第1臨床試驗收案完成;第IIa期臨床試驗收案中(Phase I completed;Phase IIa recruiting)


EXO001


惡性腫瘤
Malignant Tumors


0%

臨床前開發中 Preclinical development


INSP003


惡性腫瘤
Malignant Tumors


0%

臨床前開發中 Preclinical development